BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 517 filers reported holding BIO-TECHNE CORP in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,366,616 | -8.5% | 20,077 | +9.8% | 0.00% | 0.0% |
| Q2 2023 | $1,493,116 | -3.6% | 18,291 | -12.4% | 0.00% | -33.3% |
| Q1 2023 | $1,549,662 | -29.9% | 20,888 | -21.7% | 0.00% | -25.0% |
| Q4 2022 | $2,211,435 | +17.6% | 26,682 | +303.1% | 0.00% | 0.0% |
| Q3 2022 | $1,880,000 | -22.2% | 6,620 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $2,416,000 | -30.0% | 6,970 | -12.6% | 0.00% | -20.0% |
| Q1 2022 | $3,453,000 | -17.0% | 7,971 | -0.9% | 0.01% | -16.7% |
| Q4 2021 | $4,161,000 | +27.9% | 8,044 | +19.8% | 0.01% | +20.0% |
| Q3 2021 | $3,253,000 | -0.4% | 6,713 | -7.4% | 0.01% | 0.0% |
| Q2 2021 | $3,265,000 | +16.5% | 7,251 | -1.2% | 0.01% | 0.0% |
| Q1 2021 | $2,803,000 | +22.9% | 7,338 | +2.1% | 0.01% | +25.0% |
| Q4 2020 | $2,280,000 | +12.5% | 7,185 | -12.2% | 0.00% | 0.0% |
| Q3 2020 | $2,027,000 | +4.1% | 8,185 | +10.9% | 0.00% | 0.0% |
| Q2 2020 | $1,948,000 | +60.5% | 7,379 | +15.3% | 0.00% | +33.3% |
| Q1 2020 | $1,214,000 | -12.7% | 6,399 | +0.9% | 0.00% | 0.0% |
| Q4 2019 | $1,391,000 | +248.6% | 6,339 | +211.0% | 0.00% | -57.1% |
| Q3 2019 | $399,000 | -7.9% | 2,038 | -1.9% | 0.01% | 0.0% |
| Q2 2019 | $433,000 | -2.9% | 2,078 | -7.6% | 0.01% | -12.5% |
| Q1 2019 | $446,000 | +37.2% | 2,248 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $325,000 | +38.9% | 2,248 | +95.8% | 0.01% | +75.0% |
| Q3 2018 | $234,000 | – | 1,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 300,000 | $24,489,000 | 21.05% |
| Montanaro Asset Management Ltd | 388,800 | $31,737,744 | 5.02% |
| Sandhill Capital Partners LLC | 502,447 | $41,014,775 | 3.74% |
| Brown Capital Management | 3,160,892 | $258,023,614 | 3.66% |
| DF DENT & CO INC | 3,275,617 | $267,388,640 | 3.62% |
| Ownership Capital B.V. | 2,282,104 | $186,288,150 | 3.26% |
| Jackson Square Partners, LLC | 1,361,789 | $111,162,836 | 3.24% |
| STONE RUN CAPITAL, LLC | 88,135 | $7,194,460 | 3.20% |
| Pembroke Management, LTD | 339,591 | $27,720,813 | 2.99% |
| Summit Creek Advisors LLC | 283,693 | $23,157,860 | 2.90% |